ARCHIVES

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

This article is from The Cancer Letter archive.

Vol. 03 No. 02 | January 14, 1977

Download PDF Visit The Full Archive

Related Articles

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act

May 17, 1985

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

September 25, 1992

ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation

June 16, 1995

DCE Board Delays Decision On New Collaborative Groups In Chemoprevention

November 30, 1984